The drug Rwanda plans to roll out is the long-acting injectable Cabotegravir (CAB-LA), an intramuscular, long-acting form of PrEP. The first two injections are administered four weeks apart, followed ...

Piper Sandler analyst Jessica Tassan assigned a Buy rating to Omnicell (OMCL – Research Report) yesterday and set a price target of $69.00. The ...

According to Future Market Insights (FMI), the global asthma treatment market is poised for substantial growth, projected to hit USD 28.0 billion in 2024 and soar to USD 46.0 billion by 2034, with a ...

Although the reduction in the disparity gap was modest, the project is ongoing and appears to continue making progress.

Becker's asked pharmacy executives from hospitals and health systems across the U. S. to share their plans on improving patient care in the near future.

cHealth Technology Assessment in Primary Care and Mental Health (PRISMA), Institut de Recerca Sant Joan de Déu, Santa Rosa 39-57, Esplugues de Llobregat 08950, Spain ...

Omnicell (OMCL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stan Berenshteyn from ...

Poor medication adherence results in 125,000 deaths each year. So it’s crucial to have a system that keeps you on track.

BMW partnered with NVIDIA to enhance factory planning and operations with AI. Together they created a virtual factory, a digital twin of BMW’s production facilities. This allows BMW to simulate ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...